CADENA RESEARCH
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

CADENA RESEARCH Trademark

Serial Number: 99380465

CADENA RESEARCH is a trademark filed by Centre for Probe Development and Commercialization on September 8, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Centre for Probe Development and Commercialization (2 trademarks)

175 Longwood Rd. S.
Hamilton, Ontario L8P 0A1 , CA

Entity Type: 03

Trademark Details

Filing Date

September 8, 2025

Registration Date

Not Registered

Goods & Services

Medical and pharmaceutical consultation

Referrals in the field of testing laboratories for drug development programs; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs

Technical consulting in the field of pharmaceutical studies; Consulting services in the field of pharmaceutical research; Pharmaceutical drug development services; Medical and scientific research in the field of radiopharmaceuticals; Scientific research for medical purposes in the field of radiopharmaceuticals; Compiling data for research purposes in the field of medical science and medical consultancy; Medical and scientific research information in the field of radiopharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing information about medical and scientific research; Providing medical research information in the field of pharmaceuticals; Technical writing

Regulatory compliance consulting in the field of pharmaceuticals

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 26, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 26, 2026 GNSL
SUSPENSION LETTER WRITTEN
Mar 26, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 26, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 26, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 26, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 8, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2025 NWOS
NEW APPLICATION ENTERED
Sep 8, 2025 NWAP